Stance Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.14K Hold
811
﹤0.01% 305
2026
Q1
$2.77K Buy
+811
New +$2.73K ﹤0.01% 270
2025
Q4
Sell
-2,733
Closed -$19K 143
2025
Q3
$19K Buy
+2,733
New +$19.3K 0.01% 231
2025
Q1
Sell
-2,889
Closed -$34.3K 66
2024
Q4
$34.3K Buy
+2,889
New +$49.2K 0.02% 152

Other funds holding ASPN

Stance Capital's ASPN Position: Q2 2026 in Review

Stance Capital held its Aspen Aerogels (ASPN) position steady in Q2 2026 at 811 shares worth $5.14K. The position accounts for ﹤0.01% of the portfolio, ranked #305.

Stance Capital first reported a position in ASPN in Q4 2024 and has held it in 4 quarters since. The position peaked at $34.3K in Q4 2024. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Stance Capital held 811 shares of Aspen Aerogels worth $5.14K as of Q2 2026.
  • Stance Capital left its Aspen Aerogels share count unchanged in Q2 2026.
  • Aspen Aerogels made up ﹤0.01% of Stance Capital's portfolio in Q2 2026, its #305 holding.
  • Stance Capital first reported a position in Aspen Aerogels in Q4 2024 and has held it in 4 quarters since.
  • Stance Capital's Aspen Aerogels position peaked at $34.3K in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.